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Abstract
Suboptimal health status (SHS), a physical state between health and disease, is a subclinical and reversible stage of chronic disease. Previous studies have shown alterations in the intestinal microbiota in patients with some chronic diseases. This study
aimed to investigate the association between SHS and intestinal microbiota in a case-
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control study with 50 SHS individuals and 50 matched healthy controls. Intestinal
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SHS individuals was higher compared with that of healthy controls (Simpson index,
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microbiota was analysed by MiSeq 250PE. Alpha diversity of intestinal microbiota in
W = 2238, P = .048). Beta diversity was different between SHS and healthy controls
(P = .018). At the phylum level, the relative abundance of Verrucomicrobia was higher
in the SHS group than that in the controls (W = 2201, P = .049). Compared with
that of the control group, nine genera were significantly higher and five genera were
lower in abundance in the SHS group (all P < .05). The intestinal microbiota, analysed
by a random forest model, was able to distinguish individuals with SHS from the controls, with an area under the curve of 0.79 (95% confidence interval: 0.77-0.81). We
demonstrated that the alteration of intestinal microbiota occurs with SHS, an early
stage of disease, which might shed light on the importance of intestinal microbiota in
the primary prevention of noncommunicable chronic diseases.
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1 | I NTRO D U C TI O N

A comprehensive Suboptimal Health Status Questionnaire-25
(SHSQ-25) was used to assess SHS, with the SHSQ-25 accounting

Suboptimal health status (SHS) is a physical state between health and

for the multidimensionality of SHS by assessing the following: (a) fa-

disease and is characterized by the symptoms of health complaints,

tigue, (b) the cardiovascular system, (c) the digestive tract, (d) the

1

immune system and (e) mental status. 2 To date, the SHSQ-25 has

general weakness and low energy within a period of 3 months.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
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been validated in various populations, including Chinese,3 African4

2 | M ATE R I A L S A N D M E TH O DS

5

and European populations. Although several items of SHS are similar to some diseases, SHS cannot reach the diagnosable condition

2.1 | Study population and design

of any current defined diseases. SHS is not a disease state, but several studies have suggested that SHS, as an overall assessment of

Previously, we conducted a cross-sectional survey among under-

human body, might precede the occurrence of noncommunicable

graduates at Weifang University, which is located in Shandong

chronic diseases (NCDs), including type 2 diabetes mellitus (T2DM),

Province, China, in November 2017. In total, 5219 participants com-

cardiovascular diseases and hypertension.3-6 A cross-sectional study

pleted the questionnaire, of which 442 (8.50%) were considered

conducted among workers in urban Beijing demonstrated that SHS

suffering from SHS. 29 Among these undergraduates, 50 cases and

6

was associated with cardiovascular risk factors. In Russia, a com-

50 controls were included in this case-control study. All students

munity-based cross-sectional study showed that SHS was related

attended a standardized examination protocol in Weifang Hospital,

to endothelial dysfunction, suggesting that the integration of SHS

including an interview about the history of previous diseases, fam-

and endothelial dysfunction can be applied to the elevated risk of

ily income, physical activity, smoking status and history of drinking.

5

cardiovascular diseases. In Ghana, a cross-sectional study demon-

They received a blood biochemical examination and were asked to

strated that SHS might be involved in the development of T2DM.4 In

complete the SHSQ-25. SHSQ-25 includes 25 items: (a) item 1 to 6

a cross-sectional study of Chinese students, SHS was shown to be

and item 8 to 10 are used to measure symptoms of fatigue; (b) item

correlated with stress management, psychological states and physi-

18 to 24 are used to measure symptoms of mental status; (c) item 11

7

8

cal activity. More recently, Anto et al found that high SHS score is

to 13 are used to measure symptoms of the cardiovascular system;

associated with increased incidence of preeclampsia.

(d) item 7, 17 and 25 are used to measure symptoms of immune sys-

In China, due to modern lifestyles, increased work pressures,

tem; (e) item 14 to 16 are used to measure symptoms of the digestive

changes in diet and other factors, the prevalence of chronic diseases

tract (Table S1). 2 Participants were enrolled if they met the following

such as hypertension, heart disease, stroke, cancer, chronic obstruc-

inclusion criteria: (a) signed informed consent; and (b) a completed

tive pulmonary disease and diabetes is increasing.9 As a subclinical

questionnaire. They were excluded if they met the following exclu-

and reversible stage of chronic disease, SHS might play a very im-

sion criteria: (a) a history of somatic or psychiatric abnormalities; (b) a

portant role in the pathogenesis of chronic diseases. 2 The aetiol-

history of mental illness or drug abuse; and (c) a history of antibiotic

ogy and mechanism of SHS are still poorly understood, and SHS is

consumption in the previous 2 months. After enrolment, propensity

diagnosed based on subjective questionnaires and lacks objective

score matching was used to match a subset of 50 SHS cases (SHS

biomarkers. Shortened relative telomere length, N-glycosylation and

score ≥35) to a subset of 50 ideal healthy controls (SHS score <35)

high levels of plasma cortisol were associated with SHS, suggesting

by age, gender and body mass index (BMI). The score was calculated

10-12

that objective biomarkers have the potential to diagnose SHS.

from the SHSQ-25. The details of SHSQ-25 and the characteristics

Therefore, novel diagnostic markers based on objective measure-

of the subjects between SHS group and control group are shown in

ments are urgently needed.

Tables 1 and S2.

In recent years, many studies have shown that intestinal microbiota play important roles in host health,13 as well as the immune
system,14,15 nervous system,16 digestive system17 and cardiovascu-

2.2 | Faecal sample collection and DNA extraction

lar system,18 all of which are components of SHS. 2 Emerging evidence suggests a link between the intestinal microbiota and various
19,20

T2DM

22

Stool samples were obtained through a specimen collection kit and

and

immediately stored at −80°C. Bacterial DNA was extracted at the

acquired immune deficiency syndrome. 23 This association between

Beijing Municipal Key Laboratory of Clinical Epidemiology using a

microbiota and diseases was also validated through faecal transfer

TIANGEN kit based on the manufacturer's recommendations. The

experiments. 24-26 Furthermore, altered gut microbiota was observed

concentration and purity were evaluated using a Nanodrop® spectro-

in patients suffering from chronic fatigue syndrome (CFS), a disease

photometer (Thermo Scientific). Extracted DNA was stored at −80°C.

diseases, such as atherosclerosis,

hypertension,

21

resembling SHS. 27,28 Fremont et al27 reported that intestinal microbiota is altered in myalgic encephalomyelitis/CFS patients from
Belgium and Norway. Giloteaux et al28 found dysbiosis and translo-

2.3 | DNA sequencing of the 16S rRNA gene

cation of the intestinal microbiota in CFS. Because of the association
between intestinal microbiota and NCDs, together with SHS as an

The V4 region of the bacterial 16S rRNA gene was ampli-

early stage of NCDs, we hypothesized that the alternation of intes-

fied from extracted faecal DNA through degenerate primers

tinal microbiota might occur in SHS patients and that the interaction

(515F/806R:

might increase the incidence of NCDs. In this study, we attempted to

GGACTACHVGGGTWTCTAAT). The amplicons were purified

profile microbiota composition to identify novel bacteria associated

and quantified, according to manufacturer's protocols by Beijing

with SHS.

Cheerland Biotech Co., Ltd, China. The Polymerase chain reaction

forward

GTGCCAGCMGCCGCGGTAA,

reverse

|
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TA B L E 1 Characteristics of subjects in
SHS and healthy groups

Variables
Age (y)

Healthy group#
(n = 50)
18.96 ± 0.64

SHS group#
(n = 50)
19.00 ± 0.73

χ 2/t

1839

P

−0.29

a

.77

b

.81

Gender, male (%)

11 (22)

10 (20)

0.06

BMI (kg/m2)

22.03 ± 2.72

21.67 ± 3.03

0.62a

.53

a

.68

WHR

0.77 ± 0.05

0.77 ± 0.05

0.41

Sleeping time (h)

7.21 ± 1.20

6.92 ± 1.48

−1.06a

.29

b

.17

0.56b

.75

1.01b

.31

Physical activity, n (%)

3.58

Inactive

1 (2)

4 (8)

Moderately

15 (30)

20 (40)

Very active

34 (68)

26 (52)

Family income, n (%)
≤¥3000

22 (44)

21 (42)

¥3001-5000

19 (38)

17 (34)

≥¥5001

9 (18)

12 (24)

No smoking, n (%)

50 (100)

49 (98)

No drinking, n (%)

50 (100)

50 (100)

–

–
a

.29

SBP (mm Hg)

120.90 ± 11.51

118.30 ± 12.54

1.06

DBP (mm Hg)

77.18 ± 8.06

75.71 ± 10.80

0.77a

.45

a

.96

ALT (μg/L)

15.58 ± 9.14

15.48 ± 8.54

0.06

AST (μg/L)

21.84 ± 5.63

22.38 ± 5.91

−0.46a

.65

a

.91

−0.17a

.86

a

.24
.31

CKMB (μg/L)

9.26 ± 2.63

7.18 ± 4.46

ALP (μg/L)

62.17 ± 15.27

62.76 ± 18.20

0.11

TBIL (μg/L)

15.60 ± 6.69

14.07 ± 5.89

1.19

LDH (μg/L)

147.40 ± 23.08

142.70 ± 21.96

1.02a

Total score of
SHSQ-25

a

<.0001

17.58 ± 8.09

42.88 ± 7.24

−16.48

Fatigue score

7.16 ± 3.48

16.70 ± 2.88

−14.92a

<.0001

Cardiovascular
system score

0.44 ± 0.88

3.42 ± 2.15

−9.07a

<.0001

Digestive tract
score

1.72 ± 1.55

4.50 ± 1.99

−7.78a

<.0001

Immune system
score

2.68 ± 1.43

5.08 ± 1.60

−7.89a

<.0001

Mental status score

5.58 ± 3.41

13.18 ± 4.20

−9.94a

<.0001

Abbreviations: ¥, Chinese Yuan; ALP, alkaline phosphatase; ALT, alanine aminotransferase;
AST, aspartate aminotransferase; BMI, body mass index; CKMB, creatine kinase isoenzymes;
DBP, diastolic blood pressure; LDH, lactate dehydrogenase; SBP, systolic blood pressure; SHS,
suboptimal health status; SHSQ-25, Suboptimal Health Status Questionnaire-25; TBIL, total
bilirubin; WHR, waist-to-hip ratio.
#

Continuous variables were expressed as mean ± standard deviation, while discrete variables were
represented as number (proportion); a, t value; b, χ2 value.

(PCR) amplification was carried out in a 20 μL reaction system containing 4 μL 5× FastPfu Buffer, 2 μL 2.5 mmol L−1 dNTPs, 0.8 μL

72°C) and a final extension at 72°C for 1 minutes. PCR products
were detected by 1% agarose gel electrophoresis. The magnetic

Forward Primer (5 μmol L−1), 0.8 μL Reverse Primer (5 μmol L−1),

bead system was used to purify the replicate PCR reactions.

0.4 μL FastPfu Polymerase DNA, 10 ng Template DNA and sup-

Purified PCR amplicons of each sample were mixed, according to

plementary distillation-distillation H2O (Cheerland Biotech). The

the amplicon concentration of samples detected by Nanodrop.

procedure of PCR is as follows: denaturation (30 seconds at 98°C),

The amplicons were sequenced in a single pool in one run with

followed by 27 cycles consisting of denaturation (15 seconds at

the MiSeq platform (250 PE, Illumina), generating approximately

98°C), annealing (15 seconds at 58°C), extension (15 seconds at

5.76 Gb of data. After the raw sequences were processed to

1840
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2.6 | Ethics statement

and barcodes were sorted and matched.
This study was approved by the ethics committee of Capital Medical

2.4 | Bioinformatic analysis
Quality filtering and analyses of microbial community diversity were
performed with the QIIME1 software package (Quantitative Insights
into Microbial Ecology). Sequences were removed from the analysis
if they were <200 nt, had a quality score <20, contained ambiguous

University, Beijing, China. All subjects gave written informed consent in accordance with the Declaration of Helsinki.

3 | R E S U LT S
3.1 | Demographic profiles of SHS and the controls

characters, contained an uncorrectable barcode or did not contain
the primer sequence. Sequences were assigned to samples by exam-

In total, 50 SHS individuals consisting of 40 female and 10 male partici-

ining their individual 12-nt barcode. Sequences were aligned through

pants with an average age of 19.00 ± 0.73 years, and 50 healthy stu-

PyNAST and clustered into OTUs by 97% similarity, while taxonomy

dents with similar demographic features, composed of 39 female and

was assigned using the Ribosomal Database Project as a reference

11 male individuals with an average age of 18.96 ± 0.64 years, were se-

base. The phylogenetic tree was built with FastTree. QIIME1 and

lected in the final analysis. The SHSQ-25 score of the SHS and control

UniFrac were used for analyses of bacterial communities and group

group was 42.88 ± 7.24 and 17.58 ± 8.09, respectively (P < .0001). Five

comparisons. Alpha diversity (Chao1 index, Shannon index, Simpson

dimensions of SHS were significantly different between the healthy

index and phylogenetic diversity index) was calculated in QIIME1.

and SHS groups (cardiovascular system: 0.44 ± 0.88 vs 3.42 ± 2.15,

Across all specimens, the beta diversity distance metrics, including

fatigue: 7.16 ± 3.48 vs 16.7 ± 2.88, digestive tract: 1.72 ± 1.55 vs

unweighted and weighted UniFrac distance metrics, were calculated

4.5 ± 1.99, immune system: 2.68 ± 1.43 vs 5.08 ± 1.6, mental status:

and visualized by principal coordinates analysis (PCoA). To find fea-

5.58 ± 3.41 vs 13.18 ± 4.2; all P < .0001, Table 1). A cluster analysis

tures differentially represented between healthy and SHS groups,

was used to describe SHSQ-25 for all individuals. The SHS and healthy

linear discriminant effect size analysis (LEfSe)30 based on OTU level

samples can be clustered separately in different parts, and the cluster

was performed. LEfSe, an algorithm for high-dimensional biomarker

tree was shown in Figure S1. There were no significant differences be-

discovery, used linear discriminant analysis (LDA) to estimate the ef-

tween the SHS and control groups in demographic variables (age, sex,

fect size of each taxon differentially represented in SHS and controls.

family income, alcohol consumption, smoking history and physical activity), anthropometric measurements (BMI and WHR), blood pressure

2.5 | Statistical analysis
The Kolmogorov-Smirnov test was used for normality test. If the data

or biochemical measurements (Table 1).

3.2 | Microbial diversity

conformed to a normal distribution, continuous variables were presented as the mean ± standard deviation (SD), and an independent t

A total of 16 860 320 16S rRNA reads were obtained from the 100

test was used for analysis. If data were not normally distributed, con-

samples, with an average of 168 603 ± 97 006 reads per sample.

tinuous variables were presented as a median (interquartile range) and

After the quality filtering, 15 778 975 16S rRNA reads remained,

analysed by Wilcoxon rank-sum test. The χ2 test was used to examine

with an average of 157 790 ± 85 638 reads per sample. The num-

differences in categorical variables between the cases and controls.

ber of sequences in the smaller sample is 29 154 reads which was

Wilcoxon rank-sum tests were used to assess associations of individ-

used to compensate for differential sequencing depth. Sequences

ual taxon relative abundances. Alpha diversity was compared across

were classified into 764 ± 204 operational taxonomic units (OTUs)

groups by Wilcoxon rank-sum tests. In order to evaluate the discrimi-

per sample at the identity threshold of 97%, and 1.64% reads were

native capability of intestinal microbiota, a random forest model was

not clustered as OTU (Figure S2). The sequence-based rarefaction

established using 10-fold cross-validation, and the performance of the

curves based on the observed species were nearly asymptotic

random forest tree model was measured as the area under the curve

(Figure 1A). SHS individuals had higher microbial diversity com-

(AUC). We firstly selected variables using stepwise method in the lo-

pared with that of healthy individuals (Simpson index: Median 0.92

gistic regression and then selected variables which are statistically dif-

(P 25-P75: 0.87-0.94) vs 0.90 (0.83-0.93), P = .048; Shannon: 4.83

fered in the SHS and controls. Finally, these variables were entered

(4.25-5.26) vs 4.61 (3.64-4.99), P = .042). There is no difference

into random forest model under full factory design, and the model with

in microbial richness indices between SHS individuals and con-

highest AUC value was selected as the best model.

trols (observed species: median 757.00 (P 25-P75: 632.50-882.50)

All results were deemed significant if the P-value was below .05.

vs 785.50 (602.5-878.75), P = .931; phylogenetic diversity: 23.50

The data analysis was performed using IBM SPSS Statistics software

(20.27-27.59) vs 23.61 (17.71-27.68), P = .815; Chao1: 1011.89

(version 20.0 from Armonk, NY: IBM Corp) and R software version

(871.22-1176.25) vs 1037.91 (817.12-1153.75), P = .978; Figure 1,

3.4.2.

Table S3).

|
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F I G U R E 1 Rarefaction curves and
comparison of alpha diversity between
the gut microbiota of SHS and controls
(50 cases & 50 controls). Rarefaction
curves for the observed species of healthy
individuals and SHS individuals (A). Five
indices were used to represent the alpha
diversity, which is Observed species (B),
Simpson index (C), PD whole tree (D),
Chao1 index (E) and Shannon index (F). PD
indicates phylogenetic diversity

F I G U R E 2 Principal coordinate
analysis illustrating the grouping patterns
of the SHS and control individuals based
on the unweighted UniFrac (A) (P = .145)
and weighted UniFrac (B) distances (50
cases & 50 controls, P = .018)

Weighted and unweighted UniFrac distance metric matrices

positive correlation with Euryarchaeota (r = .28, P = .01), and AST

were used to evaluate overall differences between the two groups

had weak positive correlation with Actinobacteria (r = .26, P = .01)

through PCoA. Weighted UniFrac distance metrics in some extent

and Synergistetes (r = .23, P = .03; Table S5).

distinguished the intestinal microbiota of SHS subjects from that of
the control subjects (P = .018). There appeared to be a difference in
beta diversity between the SHS group and healthy group (Figure 2).

3.3 | Composition of faecal bacteria

On the weighted UniFrac distance metrics figure, there is a cluster
of nine healthy and one SHS at the top right corner that is clearly

At the phylum level, the majority of the 16S reads were classi-

separated from the rest of the individuals. The aspartate amino-

fied into four phyla: Firmicutes (52.92%), Bacteroidetes (33.41%),

transferase (AST) and alanine aminotransferase (ALT) were found to

Proteobacteria (9.99%) and Actinobacteria (2.44%). The two larg-

be increased in the 10 individuals (Table S4). In order to find the re-

est phyla represented in each dataset of controls and SHS groups

lationship between ALT/AST and intestinal microbiota, a Spearman's

were Firmicutes and Bacteroidetes (Figure 3). Verrucomicrobia,

correlation analysis was performed. In phylum level, ALT had a weak

Fusobacteria, Tenericutes, Euryarchaeota, TM7, Cyanobacteria

1842
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F I G U R E 3 Composition of the
intestinal microbiota of healthy individuals
and SHS patients in phylum level (A) and
family-level (B) gut microbial taxa (50
cases & 50 controls)

F I G U R E 4 Phylogenetic dendrogram
of biomarker bacteria between SHS and
control groups (50 cases & 50 controls)

and Synergistetes were also detected, representing 1% of the total

At the genus level, 352 different bacterial genera were identi-

reads analysed. At the phylum level, the relative abundance of

fied from SHS and controls in the study. The genera represented

Verrucomicrobia was considered to be higher in the SHS group than

in almost all subjects were Bacteroides (19.52%), Faecalibacterium

in the controls (P = .049; Table S6). There was no significant differ-

(15.25), Prevotella (10.21%), Escherichia (5.52%), Dialister (4.82%),

ence in ratio of Firmicutes/Bacteroidetes between SHS and control

Roseburia (4.03%) and Ruminococcus (3.5%). In SHS group, the com-

group (P = .11, Table S6).

parative abundances of Oscillospira, Pseudobutyrivibrio, Roseburia,

|

SUN et al.

Clostridiaceae,

discriminate individuals with SHS from the controls, with an AUC

unclassified Rikenellaceae, unclassified Fusobacteriaceae and

of 0.79 (95% CI: 0.77-0.81). This is the first attempt to explore the

unclassified Peptococcaceae were higher, while the relative abun-

association between SHS and intestinal microbiota.

Ruminococcus,

Chryseobacterium,

unclassified

1843

dances of Clostridiaceae 02d06, Sutterella, Ralstonia, Morganella

Alpha diversity, the mean species diversity of habitats at a local

and unclassified Peptococcaceae were lower compared with those

scale, includes two levels: richness and evenness.31 Kostic et al32

of the healthy group. (P < .05, Table S6; Figure S3). LEfSe analysis,

reported that microbial richness and the diversity of individuals de-

an algorithm for high-dimensional biomarker discovery, further

creased before the onset of type 1 diabetes. Li et al21 and Yan et al33

confirms these significant differences. Twenty-four discriminative

showed that the microbial richness and diversity of patients with hy-

features (LDA score ≥2) with relative abundances varied signifi-

pertension were dramatically decreased. In the present study, there

cantly between the SHS group and the control group (Figures 4

is no difference of the microbial richness (Chao1 index, observed

and 5). Taxon annotation of OTUs from all samples was shown in

species and phylogenetic diversity) between SHS individuals and

Table S7.

healthy controls. However, the Simpson index and Shannon index,
a comprehensive indicator of richness and evenness, in SHS indi-

3.4 | Using a random forest model to discriminate
between the SHS group and the control group

viduals were higher than that of controls, suggesting that microbial
diversity of SHS is higher than that of controls. The phenomenon of
microbial diversity decreasing in disease status but increasing in SHS
remains a mystery. The strict exclusion criteria in the definition of

A random forest approach was used to classify samples into SHS or

SHS and ideal health status, together with the homogeneity of youth

control groups. The random forest diagnosis model was validated by

undergraduates, might partly explain these disparities. Additionally,

10-fold cross-validation. The AUC for the random forest diagnostic

we showed that the beta diversity, determined by weighted UniFrac

model of SHS was 0.79 (95% CI: 0.77-0.81; Figure 6). The confusion

distance metrics, can significantly discriminate SHS subjects from

matrix of the model is shown in Table 2.

control subjects, suggesting that changed diversity of intestinal microbiota occurs in SHS before the onset of NCDs. In the Figure 2B,

4 | D I S CU S S I O N

10 individuals (nine controls and one SHS) were clearly separated
from other individuals. The AST and ALT of these 10 individuals were
within normal range, but significantly higher than those of remains,

In the present study, alpha diversity of intestinal microbiota in SHS

might suggesting that there is an association between intestinal mi-

individuals was significantly higher compared with that of healthy

crobiota and transaminases. In phylum level, ALT had a weak positive

controls. In addition, beta diversity was significantly different be-

correlation with Euryarchaeota, and AST had weak positive correla-

tween SHS and healthy controls, but the difference is not big

tion with Actinobacteria and Synergistetes. Euryarchaeota, belong

enough. Sixteen intestinal bacterial biomarkers of SHS were iden-

to archaea, is mainly composed of methanogenic bacteria which

tified by LEfSe analysis. The intestinal microbiota can effectively

indirectly affects the health of the human body.34 Abundance of

F I G U R E 5 Linear Discriminant
Analysis (LDA) score of LEfSe analysis
between SHS and control groups (50
cases & 50 controls, LDA score ≥2)

1844
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TA B L E 2

Confusion matrix for random forest analysis
Predicted

Source

Controls

SHS

Controls

37.58

13.44

SHS

12.60

36.38

Note: Values are presented as percentage.
Abbreviation: SHS, suboptimal health status.

increased in patients with gallstones compared with that of controls.48 The mechanism of cholesterol gallstone disease is associated with inflammation,49 suggesting that changes in Oscillospira
may be associated with inflammation. Ruminococcus, a member of

F I G U R E 6 Receiver operating characteristic (ROC) curve
analysis of random forest analysis in the diagnosis of SHS

the family Ruminococcaceae, has been reported to increase in colorectal cancer, 50 Alzheimer's disease51 and type 1 diabetes, 52 but
decreased in Crohn's disease. 53,54 Ruminococcus is a butyrate-pro-

Actinobacteria increased in acute-on-chronic alcohol mice while de-

ducing bacterium, and butyrate has a positive effect on human

creased in cirrhotic patients.35,36 Increased Synergistetes was found

health through anti-inflammatory effects. In this study, we ob-

in bile from individuals with opisthorchiasis.37 As mentioned above,

served that Ruminococcus decrease in SHS, and this inconsistence

these bacterial abundances are altered in several diseases, but it is

remains unexplainable. Increased Pseudobutyrivibrio and Roseburia

difficult to clarify how these bacteria affect the level of ALT/AST.

have been observed in patients with acute diverticulitis55 and

Alterations of intestinal microbiota composition are suspected

Hashimoto's

thyroiditis, 56

respectively.

Chryseobacterium,

a

to affect the host inflammatory and metabolic responses, and

gram-negative bacterium, causes endogenous infection due to low

several studies have shown that disruption of intestinal microbi-

host immunity and the irrational use of antibiotics. 57 In addition,

ota equilibrium was associated with chronic diseases.

38-41

In our

SHS individuals were also characterized by a significant reduc-

study, the large majority of all sequences identified belonged to

tion in Clostridiaceae 02d06, Sutterella, Ralstonia and Morganella.

one of four phyla, Firmicutes, Bacteroidetes, Proteobacteria or

Clostridiaceae 02d06 was enriched in T2DM patients compared

Actinobacteria, consistent with previous reports from human in-

with that in individuals without diabetes. 58 Decreased abundance

testinal microbiota studies.

42

However, the relative proportions

of Sutterella and Ralstonia were observed in patients with ulcer-

of Verrucomicrobia were significantly higher in SHS individuals

ative colitis (UC) 40 and atherosclerosis, 59 respectively. Sutterella

than in healthy controls. Previous study found that the relative

is considered to be a microorganism that induces a protective

proportions of Verrucomicrobia increased in the intestine follow-

immune regulation profile. 60 The above discussion suggests that

ing broad-spectrum antibiotic treatment.

43

This difference may be

alterations of intestinal microbiota in the SHS may involve diet

attributed to a medication history of antibiotic use. Participants

and inflammation. In the LEfSe analysis, the relative abundances

with SHS are susceptible to diseases, and they have poor resis-

of Ruminococcaceae, Oscillospira, Rikenellaceae, Verrucomicrobia,

tance to disease. Therefore, the frequency of antibiotic consump-

Order YS2 [cyanobacteria], Roseburia, Chryseobacterium, Class

tion might be higher than those of healthy. Although participants

4C0d-2 [cyanobacteria], Peptococcaceae and Ruminococcuswere

have a history of antibiotic consumption in the previous 2 months

higher in SHS individuals than in the controls, indicating that bac-

were excluded, participates used antibiotic before 2 months might

teria could be potential biomarkers for SHS.

affect the intestinal microbiota. In another study, the abundance

Several diseases can be diagnosed using intestinal microbiota.

of Verrucomicrobia was found to be modulated by the immune

Faecal microbiota can be used to discriminate Parkinson's disease

system,44 and the immune system is a component of SHS, sug-

patients from controls with an AUC of 0.81 (95% CI: 0.72-0.90),

gesting SHS leads to inflammation which causes changes in intes-

a sensitivity of 75.60% and a specificity of 77.80%.61 The intesti-

tinal microbiota. In our study, five genera, including Oscillospira,

nal microbiota was also used for the diagnosis of hypertension

Pseudobutyrivibrio, Roseburia, Ruminococcus and Chryseobacterium,

(AUC = 0.91, 95% CI: 0.75-1.00)21 and early hepatocellular carci-

were increased compared with those in controls. Konikoff et al re-

noma (AUC = 0.81, 95% CI: 0.74-0.87).62 Additionally, the micro-

ported that Oscillospira is associated with lower BMI and inflam-

biome was used for the diagnosis of several diseases, including

matory diseases and Oscillospira may utilize mammalian-derived

CFS (AUC = 0.89)28 and ileal Crohn's disease (AUC = 0.97).39 In the

glycans from host or animal protein-rich diet.

45

Some Oscillospira

present study, we also performed a supervised random forest tree

species can probably produce the important short-chain fatty acid

(RF) model to diagnose SHS, resulting in an AUC (0.79, 95% CI: 0.77-

butyrate which is important for prevention of inflammation.46,47 A

0.81). Recently, we demonstrated that plasma adrenaline/noradren-

recent study showed that the relative abundance of Oscillospira is

aline and cortisol can be used to diagnose SHS, with AUC values
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of 0.69 (95% CI: 0.65-0.73) and 0.91 (95% CI: 0.89-0.93), respectively.

63

Therefore, the combination of intestinal microbiota and

serum biochemicals, such as plasma adrenaline/noradrenaline and
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the Joint Project of the NSFC and the Australian National Health
& Medical Research Council (NHMRC) (NSFC 81561128020,
NHMRCAPP1112767).

cortisol, might increase the capability of diagnosis using objective
C O N FL I C T O F I N T E R E S T

biomarkers.
The aetiology of SHS remains unclear; however, stress responses,7 which can trigger inflammation,64 are the primarily

The authors declare no conflicts of interest associated with this
study.

recognized mechanism. We previously demonstrated that SHS is associated with mRNA expression of glucocorticoid receptors in lym-

AU T H O R S ’ C O N T R I B U T I O N S

11

phocytes, which has been implicated in inflammatory responses.

YW and WW contributed to the study design and concepts. QS, HL,

Increasing evidence has demonstrated that the disturbance of the

XM, JL and JXZ contributed to the literature research. QS, HW, JZ,

intestinal microbiota can lead to systemic inflammation.65 In addi-

QL, HL and XX contributed to the data acquisition. QS, JZ, JL, QT, MS

tion, different intestinal microbiota between the healthy and SHS

and QL contributed to the statistical analysis of data. QS, XZ, LW and

individuals were identified in terms of the relative abundance of

WC contributed to the manuscript preparation. QS and YW contrib-

specific genera. Given these findings, abnormalities in intestinal mi-

uted to the manuscript editing. All authors approved the manuscript.

crobiota might shape chronic inflammation in the gut, which subsequently leads to SHS. It highlights the association of specific taxa
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with SHS, and the identification of the underlying role of this altered
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commensal intestinal microbiota could supply novel diagnostic or
therapeutic strategies.
There are several limitations in our study that may influence the
results. First, in this study, we included more females than males,

DATA AVA I L A B I L I T Y S TAT E M E N T
The data that support the findings of this study are available from
the corresponding author upon reasonable request.

which might introduce selection bias in the association between
intestinal microbiota and SHS. The prevalence of SHS is higher in
females than that in males, and the response rate in faecal sample
collection is also higher in females than in males. To increase the
comparability between groups, we matched SHS cases and controls
using propensity score matching based on age, gender and BMI.
Second, the design of a case-control study based on a cross-sectional study makes it inevitable to avoid selection bias and may
overestimate the accuracy of diagnosis for SHS. Third, the diet of
participants, the main associated factor of the intestinal microbiota,66 was not controlled, which might introduce confounding bias.
Forth, the cortisol and adrenaline/noradrenaline, the only known
measurable biochemical parameter of SHS, were not included in our
study. Finally, the sample size of our study is relatively small, resulting in the absence of statistical power. Therefore, further cohort
studies with larger sample sizes are needed to explore the causal
association between SHS and the intestinal microbiota.

5 | CO N C LU S I O N
In this case-control study with a relatively small sample size, we first
demonstrated that the intestinal microbiota is associated with SHS.
Alteration of intestinal microbiota occurs with SHS, an early stage
of disease, which might shed light on the importance of intestinal
microbiota in the primary prevention of NCDs.
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